22 May 2013
Keywords: imigran, approved, germany, glaxo, received, approval, market
Article | 04 January 1993
- Glaxo has received approval to market Imigran (sumatriptan), its
antimigraine product, in Germany. The license is for both the oral ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 January 1993
21 May 2013
© 2013 thepharmaletter.com